Table 3.
Study | Measurement tools | Results |
Chad et al [25] | McMurtry children’s fear scale | Significant reduction in fear detected by parent due to VRa (mean 2.18; P=.05). Insignificant reduction in fear reported by child due to VR (mean 2.57; P=.43). |
Frey et al [28] | VNSb (scale of 0-10) | Anxiety was significantly decreased –1.5 (95% CI –0.8 to –2.3) in the VR condition compared to that in the control condition. Significant difference in anxiety found between VR group and non-VR group using ANOVAc. |
Gershon et al [30] | VASd (scale of 0-100); CHEOe Pain Scale | From the CHEO pain scale measure, the VR group had significantly fewer behavioral markers in comparison to controls for anxiety (P<.05). No summary measures were provided in paper. |
Glennon et al [31] | 5-point Likert scale for anxiety | Participants in the VR group did not experience a statistically significant decrease in anxiety in comparison to that in controls (P>.05). |
Gold et al [32] | VAS (scale of 0-10); FASf | Significantly less anxiety (P<.05)was reported and observed in the VR group (mean 1.90, SD 2.2) compared to that in the control group (mean 2.48, SD 2.07). |
McSherry et al [33] | VNS | Anxiety scores were not significantly reduced (P>.05) in VR group (mean difference –1.3, SD 4.4) vs control (mean difference –0.4, SD 2.7). |
Piskorz et al [35] | VAS | The VR group (mean 11.16, SD 18.58) reported significantly lower stress levels (P<.01) compared to those in the control group (mean 41.89, SD 40.89). Stress levels were 73.4% lower in VR group against control with a large effect size (Cohen d= 0.993). |
Walker et al [38] | VAS | No significant difference between intraprocedural anxiety levels. No descriptive statistics were provided. |
aVR: virtual reality.
bVNS: verbal numerical scale.
cANOVA: analysis of variance.
dVAS: visual analog scale.
eCHEO: Children’s Eastern Ontario Hospital.
fFAS: facial affective scale.